A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity.
Fujiwara H, Kubota M, Hidaka Y, Ito K, Kawahara T, Kurahashi R, Hattori Y, Shiraishi Y, Hama Y, Makita N, Tashiro Y, Hatano S, Ikeuchi R, Nakashima M, Utsunomiya N, Takashima Y, Somiya S, Nagahama K, Fujimoto T, Shimizu K, Imai K, Takahashi T, Sumiyoshi T, Goto T, Morita S, Kobayashi T, Akamatsu S.
Fujiwara H, et al. Among authors: hatano s.
Int J Clin Oncol. 2024 Oct;29(10):1574-1585. doi: 10.1007/s10147-024-02577-1. Epub 2024 Jul 19.
Int J Clin Oncol. 2024.
PMID: 39028395
Free PMC article.